Australia

Australia’s TGA proposes fee increases to implement recent drug, device reforms

January 28, 2020

PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) is seeking input from industry stakeholders on a proposal to increase its fees to cover projected deficits this year.

Bringing glaucoma risk into focus

Multitrait analysis predicts glaucoma susceptibility, progression

January 28, 2020

By John Fox

No Comments

An international collaborative study led by geneticists at the Queensland Institute of Medical Research Berghofer Medical Research Institute (QIMR) in Brisbane, Australia, has used a multivariate approach to develop a polygenic risk score (PRS) for glaucoma.

Bringing glaucoma risk into focus

Multitrait analysis predicts glaucoma susceptibility, progression

January 24, 2020

By John Fox

No Comments

An international collaborative study led by geneticists at the Queensland Institute of Medical Research Berghofer Medical Research Institute (QIMR) in Brisbane, Australia, has used a multivariate approach to develop a polygenic risk score (PRS) for glaucoma.

Australia’s TGA proposes fee increases to implement recent drug, device reforms

January 24, 2020

By Tamra Sami

No Comments

PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) is seeking input from industry stakeholders on a proposal to increase its fees to cover projected deficits this year. The proposal outlines three options.

Australia’s TGA proposes fee increases to implement recent drug, device reforms

January 23, 2020

By Tamra Sami

No Comments

PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) is seeking input from industry stakeholders on a proposal to increase its fees to cover projected deficits this year. The proposal outlines three options.

Noxopharm spin-off Nyrada lists on ASX raising AU$8.5 million in oversubscribed IPO

January 21, 2020

By Tamra Sami

No Comments

PERTH, Australia – Sydney-based Noxopharm Ltd. announced that its spin-off, Nyrada Inc., began trading on Australia’s Securities Exchange (ASX:NYR) on Jan. 16, following an oversubscribed IPO that raised AU$8.5 million (US$5.8 million).

Australia amends first tranche of broad medical device regulations

January 17, 2020

By Tamra Sami

No Comments

PERTH, Australia – Australia’s Parliament has passed the first tranche of medical device regulations reforms that follow a number of consultations over the last two years.

Noxopharm spin-off Nyrada lists on ASX raising AU$8.5 million in oversubscribed IPO

January 16, 2020

By Tamra Sami

No Comments

PERTH, Australia – Sydney-based Noxopharm Ltd. announced that its spin-off, Nyrada Inc., began trading on Australia’s Securities Exchange (ASX:NYR) on Jan. 16, following an oversubscribed IPO that raised AU$8.5 million (US$5.8 million).

As bushfires continue to burn, Australia’s regulators don’t anticipate delays

January 14, 2020

By Tamra Sami

No Comments

PERTH, Australia – Although Australia’s deadly bushfires continue to burn, Australia’s Therapeutic Goods Administration (TGA) is not anticipating any effect on business operations.

As bushfires continue to burn, Australia’s regulators don’t anticipate delays

January 8, 2020

By Tamra Sami

No Comments

PERTH, Australia – Although Australia’s deadly bushfires continue to burn, and conditions are expected to worsen later this week as temperatures rise, Australia’s Therapeutic Goods Administration (TGA) is not anticipating any effect on business operations.